Redox has partnered with Voluntis, a digital therapeutics company, to allow providers to automate and adapt insights on their patients’ treatment journey within their electronic health records (EHR) to enhance care and collaboration, the company announced recently.

According to a release, the two companies will integrate Voluntis’ digital therapeutics platform, Theraxium, with Redox’ interoperability platform.

“As we navigate a challenging time in healthcare, it’s exciting to see companies like Voluntis paving the way for the future of how digital health solutions are brought to market and the extensive value they deliver,” Redox President Niko Skievaski said in a statement. “We’re proud of our work with Voluntis to find more advanced ways to create a frictionless information workflow to improve care and outcomes.”

Financial terms of the deal were not disclosed.